Stelexis BioSciences
Stelexis BioSciences
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-25 | NCT06533761 | |
| Study of STLX-2012 in Healthy Volunteers | Healthy Participants | Not yet recruiting | Phase 1 | 2026-04-22 | NCT07231744 |